Table 3 Multivariate analysis of prognostic factors in the validation set with peritoneal recurrence-free survival as an end point
Variate | Hazard ratio | 95% confidence interval | P -value |
|---|---|---|---|
Tumour size | |||
⩽5 cm | 1 | ||
>5 cm | 0.32 | 0.06–1.68 | 0.1800 |
Histological type | |||
Differentiated | 1 | ||
Undifferentiated | 2.64 | 0.55–12.70 | 0.2300 |
Serosal invasion | |||
Negative | 1 | ||
Positive | 155.09 | 2.02E−10–1.19E+14 | 0.7200 |
Lymph node metastasis | |||
Negative | 1 | ||
Positive | 0.65 | 0.21–1.97 | 0.4400 |
CEA mRNA status | |||
Negative | 1 | ||
Positive | 3.99 | 1.80–8.84 | 0.0006 |
